PURPOSE: Dominant-active RAC1 rescues photoreceptor structure in Drosophila rhodopsin-null mutants, indicating an important role in morphogenesis. This report assesses the morphogenetic effect of activated RAC1 during mammalian rod photoreceptor development using transgenic mice that express constitutively active (CA) RAC1. METHODS: Transgenic mice were generated by expressing CA RAC1 under control of the Rhodopsin promoter, and morphological features of the photoreceptors were evaluated by histology, immunohistochemistry, and transmission electron microscopy. Function was evaluated by electroretinography. Potential protein partners of CA RAC1 were identified by co-immunoprecipitation of retinal extracts. RESULTS: Constitutively active RAC1 expression in differentiating rods disrupted outer retinal lamination as early as postnatal day (P)6, and many photoreceptor cell nuclei were displaced apically into the presumptive subretinal space. These photoreceptors did not develop normal inner and outer segments and had abnormal placement of synaptic elements. Some photoreceptor nuclei were also mislocalized into the inner nuclear layer. Extensive photoreceptor degeneration was subsequently observed in the adult animal. Constitutively active RAC1 formed a complex with the polarity protein PAR6 and with microtubule motor dynein in mouse retina. The normal localization of the PAR6 complex was disrupted in CA RAC1-expressing rod photoreceptors. CONCLUSIONS: Constitutively active RAC1 had a profound negative effect on mouse rod cell viability and development. Rod photoreceptors in the CA RAC1 retina exhibited a defect in polarity and migration. Constitutively active RAC1 disrupted rod morphogenesis and gave a phenotype resembling that found in the Crumbs mutant. PAR6 and dynein are two potential downstream effectors that may be involved in CA RAC1-mediated defective mouse photoreceptor morphogenesis.
PURPOSE: Dominant-active RAC1 rescues photoreceptor structure in Drosophilarhodopsin-null mutants, indicating an important role in morphogenesis. This report assesses the morphogenetic effect of activated RAC1 during mammalian rod photoreceptor development using transgenic mice that express constitutively active (CA) RAC1. METHODS:Transgenic mice were generated by expressing CA RAC1 under control of the Rhodopsin promoter, and morphological features of the photoreceptors were evaluated by histology, immunohistochemistry, and transmission electron microscopy. Function was evaluated by electroretinography. Potential protein partners of CA RAC1 were identified by co-immunoprecipitation of retinal extracts. RESULTS: Constitutively active RAC1 expression in differentiating rods disrupted outer retinal lamination as early as postnatal day (P)6, and many photoreceptor cell nuclei were displaced apically into the presumptive subretinal space. These photoreceptors did not develop normal inner and outer segments and had abnormal placement of synaptic elements. Some photoreceptor nuclei were also mislocalized into the inner nuclear layer. Extensive photoreceptor degeneration was subsequently observed in the adult animal. Constitutively active RAC1 formed a complex with the polarity protein PAR6 and with microtubule motor dynein in mouse retina. The normal localization of the PAR6 complex was disrupted in CA RAC1-expressing rod photoreceptors. CONCLUSIONS: Constitutively active RAC1 had a profound negative effect on mouse rod cell viability and development. Rod photoreceptors in the CA RAC1 retina exhibited a defect in polarity and migration. Constitutively active RAC1 disrupted rod morphogenesis and gave a phenotype resembling that found in the Crumbs mutant. PAR6 and dynein are two potential downstream effectors that may be involved in CA RAC1-mediated defective mouse photoreceptor morphogenesis.
Entities:
Keywords:
RAC1; lamination; mouse rod morphogenesis; photoreceptor degeneration; positioning and polarity
Authors: Bokyung Park; Celso Henrique Alves; Ditte M Lundvig; Naoyuki Tanimoto; Susanne C Beck; Gesine Huber; Fabrice Richard; Jan Klooster; Till F M Andlauer; Eric C Swindell; Milan Jamrich; André Le Bivic; Mathias W Seeliger; Jan Wijnholds Journal: J Neurosci Date: 2011-11-23 Impact factor: 6.167
Authors: Masatoshi Haruta; Ronald A Bush; Sten Kjellstrom; Camasamudram Vijayasarathy; Yong Zeng; Yun-Zheng Le; Paul A Sieving Journal: Proc Natl Acad Sci U S A Date: 2009-05-21 Impact factor: 11.205
Authors: Dianne C Mitchell; Brad A Bryan; Jin-Ping Liu; Wen-Bin Liu; Lan Zhang; Jia Qu; Xiangtian Zhou; Mingyao Liu; David W Li Journal: Mol Vis Date: 2007-07-13 Impact factor: 2.367
Authors: Zachary C Wright; Ratnesh K Singh; Ryan Alpino; Andrew F X Goldberg; Maxim Sokolov; Visvanathan Ramamurthy Journal: Hum Mol Genet Date: 2016-03-02 Impact factor: 6.150
Authors: Ronja Hollstein; David A Parry; Lisa Nalbach; Clare V Logan; Tim M Strom; Verity L Hartill; Ian M Carr; Georg C Korenke; Sandeep Uppal; Mushtaq Ahmed; Thomas Wieland; Alexander F Markham; Christopher P Bennett; Gabriele Gillessen-Kaesbach; Eamonn G Sheridan; Frank J Kaiser; David T Bonthron Journal: J Med Genet Date: 2015-09-30 Impact factor: 6.318
Authors: Yong Zeng; Ronald S Petralia; Camasamudram Vijayasarathy; Zhijian Wu; Suja Hiriyanna; Hongman Song; Ya-Xian Wang; Paul A Sieving; Ronald A Bush Journal: Invest Ophthalmol Vis Sci Date: 2016-07-01 Impact factor: 4.799
Authors: Eduardo Zabala Aldunate; Valentina Di Foggia; Fabiana Di Marco; Laura Abelleira Hervas; Joana Claudio Ribeiro; Daniel L Holder; Aara Patel; Tommaso B Jannini; Dorothy A Thompson; Juan Pedro Martinez-Barbera; Rachael A Pearson; Robin R Ali; Jane C Sowden Journal: Sci Rep Date: 2019-02-19 Impact factor: 4.379
Authors: Arpad Palfi; Karsten Hokamp; Stefanie M Hauck; Sebastian Vencken; Sophia Millington-Ward; Naomi Chadderton; Mathew Carrigan; Elod Kortvely; Catherine M Greene; Paul F Kenna; G Jane Farrar Journal: Sci Rep Date: 2016-08-16 Impact factor: 4.379
Authors: Zachary C Wright; Yuriy Loskutov; Daniel Murphy; Peter Stoilov; Elena Pugacheva; Andrew F X Goldberg; Visvanathan Ramamurthy Journal: Sci Rep Date: 2018-11-16 Impact factor: 4.379